NCT00929981View on ClinicalTrials.gov

A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Dermatitis, Contact
Interventions
DRUG

Tablet Methylprednisolone (4 or 16 mg)

Oral Methylprednisolone tablets (4mg, 16mg) will be given as per locally approved prescribing information

Trial Locations (4)

141001

Pfizer Investigational Site, Ludhiana

560 038

Pfizer Investigational Site, Bangalore

400 058

Pfizer Investigational Site, Mumbai

421 201

Pfizer Investigational Site, Mumbai

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY